CRP and irritable bowel syndrome: CRP and hemoglobin are helpful insofar as they are reflective of the clinical response to infliximab induction and can help differentiate common concurrent diagnoses such as irritable bowel syndrome or chronic pain syndrome, which may obscure clinical response.